Our lung disease-derived PBMCs are isolated from peripheral blood of donors diagnosed with chronic respiratory conditions, including idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), asthma, and lung cancer. These highly viable, cryopreserved PBMCs retain functional immune cell populations, including T cells, B cells, NK cells, and monocytes, making them ideal for immunological studies, biomarker discovery, and therapeutic response evaluations related to lung diseases.
 
Supplied with detailed donor clinical histories, including disease type and severity, these PBMCs support translational research in immune profiling, inflammation studies, and the development of targeted immunotherapies for pulmonary conditions. Custom donor selection is available upon request to meet specific experimental needs.